Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
 Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, FL

Trial Information

Research Study for Chronic Obstructive Pulmonary Disease

This is a research study for chronic pulmonary disease (COPD). Subjects who meet the criteria at Screening and meet the randomization criteria at the end of a Run In period will then enter the treatment phase of the study. Participation could last from 7 to 15 weeks.
The study will screen approximately 100 patients at 10-15 study sites across the United States to enroll 84 subjects.

Patient Inclusion Criteria:

  • Subjects 40-80 years old
  • Current and former smokers will be accepted
  • Subjects must have greater than a 10 pack year smoking history
  • Males and Females will be accepted

Additional criteria will be reviewed with the subject.
Volunteers will be asked to come to the clinic for up to 9 visits. All study related medical examinations, laboratory tests and study medication are provided to qualified participants at no cost.

Jessica Elkins Hochstetler RN, CCRC, Director of Clinical Research
Emerald Coast Research Associates
221 East 23rd Street Suite B
Panama City, FL 32405
Phone: 850-785-6550
Fax: 850-785-6804
Email: jesselkins@bellsouth.net

View Map

Research Center Information: Emerald Coast Research Associates

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.